Kimberly-Clark to acquire Tylenol's parent company in nearly $49B deal
Summary
Kimberly-Clark plans to buy Kenvue, the company that owns Tylenol, for nearly $49 billion. This deal could impact both consumers and shareholders.Key Facts
- Kimberly-Clark is a large consumer products company.
- Kenvue owns the Tylenol brand.
- The acquisition deal is worth nearly $49 billion.
- Discussions have focused on how this deal might affect consumers and shareholders.
- The announcement was made on November 4, 2025.
